about
Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine.Febrile seizures after 2009 influenza A (H1N1) vaccination and infection: a nationwide registry-based study.Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of epilepsy patients.[In vivo magnetic resonance spectroscopy].Utilizing national patient-register data to control for comorbidity in prognostic studies.Comparison of data from the Cause of Death Registry and the Norwegian Patient Register.Strong decline in female sterilization rates in Norway after the introduction of a new copayment system: a registry based study.Gambling problems in the family--a stratified probability sample study of prevalence and reported consequences.Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up studyHealth care resource use by patients before and after a diagnosis of chronic fatigue syndrome (CFS/ME): a clinical practice research datalink study.Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children.Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012.Comparison of data from the Norwegian Patient Register and the Cancer Registry of Norway.Incidence of traumatic cervical spine fractures in the Norwegian population: a national registry study.Comorbidities treated in primary care in children with chronic fatigue syndrome / myalgic encephalomyelitis: A nationwide registry linkage study from NorwayThe quality of severe mental disorder diagnoses in a national health registry as compared to research diagnoses based on structured interview.Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.Chlamydia trachomatis and ectopic pregnancy: recent epidemiological findings.[Chlamydia infections in South Trøndelag--treatment and follow-up].[Chlamydia trachomatis infection in central Norway--testing patterns and prevalence].Norwegian men diagnosed with genital Chlamydia trachomatis infection notified two-thirds of their sexual partners.Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis.Chlamydia trachomatis among young Norwegian men: sexual behavior and genitourinary symptoms.Chlamydia trachomatis infections increase the risk for ectopic pregnancy: a population-based, nested case-control study.Chlamydia trachomatis testing patterns and prevalence of genital chlamydial infection among young men and women in central Norway 1990-2003: a population-based registry study.[Testing pattern and prevalence of Chlamydia infections among men].[Testing pattern and prevalence of Chlamydia infection among women].[Detection of chlamydia trachomatis in urine, vulval and cervical swabs].[Chlamydia trachomatis infection in women seeking termination of pregnancy 1985-2000].[Chlamydia infections and sexual behavior among young women].HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway.Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study.ADHD treatment and diagnosis in relation to children's birth month: Nationwide cohort study from Norway.Completeness and correctness of cerebral palsy diagnoses in two health registers: implications for estimating prevalence.Percutaneous Coronary Intervention as a Trigger for Stroke.Comorbidity and Childhood Epilepsy: A Nationwide Registry Study.Pandemic Influenza A H1N1 Vaccination and Subsequent Risk of Type 1 Diabetes in Norway.Comparison of the validity of stroke diagnoses in a medical quality register and an administrative health register.
P50
Q30374961-9E7B005B-99BC-4CB2-83F0-61CE12F6DCADQ30380365-6B3463CD-8D1A-4AE5-B447-CED2CD54D17FQ30381202-C97F71DE-F3C6-4A1C-B83E-489843BCFFA5Q30400010-CB63312C-5C33-4008-B33D-5E2A7F7672FEQ30579472-7B8E2290-D933-45C3-8DCC-CD6B43E3AD17Q30701434-8B264298-139F-4589-8FBA-697EECCCC0F1Q30867393-3F483124-DCEB-4913-AFFA-994F1774DEA7Q31024844-13A4754B-5661-4CF2-B159-D42888DE814EQ33295237-244990BA-3CE7-4B1A-B08C-C3557435E4A4Q33393495-D022D1D2-B7EF-4C07-BAFA-558FA9E6F1A2Q33493226-D2EBB432-292D-47B8-8B62-B9C39C762164Q33644694-D0C47CDC-2C11-4817-BB51-6D330BAB9316Q33819459-4458E995-F315-47C7-BC16-94F9B6683A14Q34306149-DB09B11C-2062-4690-8E70-50CD0496712EQ34311173-5D0D1A84-CA8B-412C-963D-1D3E3FF78E50Q34986804-657D7A47-C2C9-4C98-B1D9-0856C3142AC6Q36122141-BA9519AD-F5F4-4739-B996-317D14B91413Q36307768-E30A5A4C-BDBA-487F-915F-E9CD38A232D0Q36634198-EC78D8E8-1C99-458A-AD86-46659A4191D2Q37056130-32E030A5-6C30-499E-821A-D68EB2DDFDABQ37851232-7D5370DC-5A40-4C62-A276-82764E707386Q37858454-CF72F1B1-7129-486D-8411-40A5AFA6E1C8Q37858981-DF36430C-A68D-41DE-945F-3F69015A7A99Q37859864-00DB3FF4-2F88-42AC-BA0B-187D78D92212Q37861611-482E71AF-CBAD-404F-A5DC-0081ADD2E3E7Q37861849-DD55E31F-81B0-4AE8-B781-A8DF461CBDF4Q37863248-FDB4AF99-B89A-48C6-B82A-E803DC9E50C0Q37864539-51DA8D6F-A1A9-4479-81EA-EB96578C3DB9Q37864542-06E58727-5A60-4BBB-BA39-433BA46C7FA2Q37864545-1F82BD39-617E-496D-9DD3-1DB1BBFD256BQ37866834-E1AFDCBF-3069-4C25-924D-1333E0F72822Q37866840-99716FB6-5345-430A-BCD5-A688452F6308Q38709953-D2DC9F52-7F17-4630-9A5B-DEE501B8AA28Q38756470-8552806F-3786-4C0C-8FB7-42C57EEB8AC6Q38797673-6A1AEE57-F41F-4BD6-B64E-1A838A9AF6E2Q39023275-CEB67811-925E-4CEF-9ACF-F2194DFEA730Q39253673-9D10D2AE-3394-4598-A80B-2B26C3C7EE94Q39534859-7AB26590-5024-4CA0-AFBE-884CF7C9CE67Q40051180-B64818B9-36CE-4B63-8717-C1E76DF117D5Q40218769-38FCCD2A-7A8E-46CE-9B9B-0E3E4991D3CA
P50
description
Noors onderzoekster
@nl
hulumtuese
@sq
norsk forsker
@nb
researcher
@en
ricercatrice
@it
taighdeoir
@ga
հետազոտող
@hy
name
Inger Johanne Bakken
@ast
Inger Johanne Bakken
@da
Inger Johanne Bakken
@de
Inger Johanne Bakken
@en
Inger Johanne Bakken
@es
Inger Johanne Bakken
@fr
Inger Johanne Bakken
@ga
Inger Johanne Bakken
@nb
Inger Johanne Bakken
@nl
Inger Johanne Bakken
@nn
type
label
Inger Johanne Bakken
@ast
Inger Johanne Bakken
@da
Inger Johanne Bakken
@de
Inger Johanne Bakken
@en
Inger Johanne Bakken
@es
Inger Johanne Bakken
@fr
Inger Johanne Bakken
@ga
Inger Johanne Bakken
@nb
Inger Johanne Bakken
@nl
Inger Johanne Bakken
@nn
altLabel
Inger J Bakken
@en
Inger J. Bakken
@nb
Inger Johanne Landsjøåsen Bakken
@en
Inger Johanne Landsjøåsen Bakken
@nb
prefLabel
Inger Johanne Bakken
@ast
Inger Johanne Bakken
@da
Inger Johanne Bakken
@de
Inger Johanne Bakken
@en
Inger Johanne Bakken
@es
Inger Johanne Bakken
@fr
Inger Johanne Bakken
@ga
Inger Johanne Bakken
@nb
Inger Johanne Bakken
@nl
Inger Johanne Bakken
@nn
P108
P106
P108
P21
P214
4801149198373174940006
P2287
P27
P31
P496
0000-0002-4176-8257
P734
P7859
viaf-4801149198373174940006